Cigna to answer more than 150 benefits-related questions via Amazon Alexa

Cigna has announced the launch of “Answers by Cigna," an additional skill to the Amazon Alexa voice-controlled device that aims to improve patient health literacy.

According to a 2017 survey, 20 percent of patient respondents did not know what the word “premium” meant and 66 percent did not understand the word “formulary.” Patients with low literacy in health-related terms ultimately have lower utilization of its benefits. In response to low literacy rates, the health insurer designed “Answers by Cigna” to use the voice-controlled device to personalize and simplify health benefits information.

To enable the “Answers by Cigna” skill for Alexa, users can either download it through the Amazon Alexa Skills Store or by vocalizing, “Alexa, enable Answers by Cigna.” Users then ask Alexa their health-related questions. The hands-free skill is currently able to provide instant answers to more than 150 commonly-asked healthcare questions.

“Voice control offers an exciting and innovative way for Cigna to educate and engage people about health care in a way that is convenient for them,” said Rowena Track, vice president of digital marketing at Cigna. “The applications for voice control are expanding every day and we see great potential as we continue to simplify and personalize our customers’ health care journeys. Our work with Amazon Alexa provides us with experience and expertise as we evolve our voice platform and introduce new personalized services throughout the year.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.